Search results
You searched for:
Found 1,518 results
Sorting options:
Date: 01/01/2026 Location: Other
Prescribing Opioids is a 3-hour online education activity. The broad goals are to enhance participants' skills and confidence in:Identifying patients who are drug-dependent (or at risk of this) or drug-seeking, and ways to minimise harmEstablishing boundaries with patients and managing their expectations about opioidsUnderstanding lawful and good practice prescription of opioids.
1.5 Educational activity hours
1.5 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This online module provides participants with an introduction to Open Disclosure. It considers the Open Disclosure framework, relevant guidelines and key components of the Open Disclosure process. Partiicipants consider the barriers and benefits of Open Disclosure and reflect on their own workplace.
0.5 Educational activity hour
0.5 Performance review hour
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
In Australia the primary strategy is vaccination with immunisation against HPV. Secondary prevention is through cervical screening under the NCSP. The change in the National Cervical Screening Program in 2017 from the biennial Pap smear test for asymptomatic patient to the 5-yearly HPV DNA test reflects the advances in understanding of the epidemiology HPV. At the time that the new program began, self-collected vaginal swab samples for HPV DNA testing were offered as a new approach to increase access to the NCSP for the group of women who were previously under-screened or never-screened. In 2021 the extensive evidence review undertaken by the Medical Services Advisory Committee (MSAC) assessed the acceptability for self-collection and adherence to follow up when HPV is detected in eight studies. Findings showed a high level of acceptability for sample, with most women who had collected a swab, finding it easy to perform and less embarrassing. In the three studies that considered adherence to follow up, the study populations were undertaken with under-screened women, therefore the data may not necessarily reflect applicability to the wider screening population. Adherence ranged from 52 -82%. The MSAC evidenced based recommendation was introduced from 1 July 2022.
3 Performance review hours
10 Outcome measurement hours
Addressing health inequities
Culturally safe practice
Ethical practice
Professionalism
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on the major phytocannabinoids: THC and CBD. The course provides a comprehensive examination of the two main cannabinoids, tetrahydrocannabinol (THC) and cannabidiol (CBD). It distinguishes between their main actions and analyses their synergistic relationship. Chemical structures and how they work are explained. Various trial results are discussed and safety guides discussed. Given that THC and CBD interact differently within the endocannabinoid system and with other neurotransmitters, the course considers their different therapeutic potential.
4 Educational activity hours
5 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
Every year, millions of Australians embark on journeys abroad, with Indonesia, New Zealand, USA, UK, and Japan among the most popular destinations. General Practitioners frequently field requests for detailed travel advice to aid in planning a safe and tailored plan for a trip. This plan hinges on various factors such as the travel destination, timing, individual medical history, purpose of the trip and more. This seminar aims to tackle these complexities, arming participants with the knowledge to effectively address travel-related enquiries.
7.5 Educational activity hours
4 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
The data from a minimum of 12 recent surgical cases will be collated from the participating GPs surgical log or via Sonic Healthcare’s Sonic Dx app if the patients have been referred to a Sonic Healthcare Laboratory. These cases must include at least one procedure to exclude or confirm melanoma, and at least two procedures to diagnose and/or treat non-melanoma skin cancer. As GPs have very individual practices, there will be a set minimum of 10 cases for review. Participants may include non – concurrent cases but we would hope that all cases analysed would have been seen within the last 12 months.
2 Educational activity hours
6 Performance review hours
6 Outcome measurement hours
Culturally safe practice
Professionalism
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on routes of administration, side effects and contra indications. The course discusses the safe use of medicinal cannabis, outlining the routes of administration, side effects, and contraindications. Cannabinoid pharmacokinetics are also examined, including its absorption following diverse administration routes, metabolism by different tissues and organs, bioavailability and elimination from the body. Despite its extreme safety as a medication generally and particularly relative to opioids, potential adverse effects and contrindicaitons of cannabis are outlined. The course also analyses the potential for drug-to-drug interaction given CBD and THC’s effects on common biological pathways implicated in drug metabolism via their interactions with cytochrome P450 enzymes specifically.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focusses on patient cases and basic ailments. The course identifies a number of basic ailments that may be successfully treated with medical cannabis in General Practice. For example, the adverse effects of cancer treatment, the symptoms of chronic pain, anxiety, depression, and insomnia could be alleviated by medicinal cannabis with mild side effects and minimal risk of toxicity or addiction. Providing that conventional treatments have failed or caused unacceptable side effects, a growing number of conditions lend themselves to treatment with cannabis. Given the complex chemical profile, there is a single medication potential to assist with multiple symptoms, thereby reducing polypharmacy. The course applies an individualised management plan to three comprehensive case studies for patients with chronic pain, osteoarthritis, and anxiety and depression. Considerations ranging from the cost to the patient to the appropriate THC to CBD ratio are addressed. Finally, the course guides the practitioner in navigating an application for a TGA Special Access Scheme/SAS B.
4.5 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on using medicinal cannabis for managing chronic pain. The course discusses the use of medicinal cannabis as an emerging option for clinicians to reduce and alleviate difficult-to-treat, chronic, neuropathic pain. It includes analyses of the endocannabinoid system and the diverse, multimodal mechanisms of cannabinoid-induced analgesia. THC and CBD are an excellent additive treatment to concurrent conventional pain management for many chronic pain types associated with a range of diseases such as fibromyalgia, traumatic injury, and multiple sclerosis. For patients suffering from neuropathic pain, cannabinoids may be used successfully as an adjunctive, opioid-sparing, or ultimately a replacement therapy for managing their pain. The course also discusses a management plan’s necessary considerations such as determining dosages and accounting for safety considerations, and applies these protocols to a chronic pain case study.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice
Date: 01/01/2026 Location: Other
This medicinal cannabis course focuses on anxiety, insomnia and depression. The course examines the homeostatic functions of the endocannabinoid system in relation to mood, stress response, and sleep. It also evaluates the therapeutic capacity of the major cannabinoids (THC and CBD), in isolation and in synergy, in relation to anxiety, depression, and insomnia. In developing a treatment plan, essential factors such as the interplay between depression, anxiety, pain, and insomnia are considered, as well as protocols for THC to CBD ratios in basic dosing, and the route and timing of administration with reference to each condition. With regard to treating insomnia particularly, the course addresses the role of other lesser-known cannabinoids, such as CBN, and terpenes. Pertinent considerations such as the dampening effect of CBD upon the undesirable effects of THC such as intoxication, tachycardia and psycho-activity (particularly important when treating anxiety) are also discussed.
4 Educational activity hours
6 Performance review hours
Professionalism
Ethical practice